Global Carbohydrate Antigen 19-9 Market Size, Share, Trends and Forecast 2022-2030

Description

Carbohydrate antigen 19-9 is a tetrasaccharide which is usually attached to O-glycans on the surface of cells. It is known to play a vital role in cell-to-cell recognition processes. It is also a tumor marker used primarily in the management of pancreatic cancer.
Industry Insights

Due to the COVID-19 pandemic, the global Carbohydrate Antigen 19-9 market size is estimated to be worth US$ 94 million in 2021 and is forecast to a readjusted size of US$ 145.9 million by 2028 with a CAGR of 6.4% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Carbohydrate Antigen 19-9 market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Carbohydrate Antigen 19-9 landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Global Carbohydrate Antigen 19-9 main manufactuers include Abbott, Ropv and Ortho Clinical Diagnostics. In terms of the type of Carbohydrate Antigen 19-9, it can be divided into ELISA and CLIA. CLIA is the largest market, with a share over 70%.

This report focuses on Carbohydrate Antigen 19-9 volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Carbohydrate Antigen 19-9 market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Carbohydrate Antigen 19-9 market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

ELISA

CLIA

Segment by Application

Pancreatic Cancer

Colon Cancer

Stomach Cancer

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Abbott

Roche

Ortho Clinical Diagnostics

BioMérieux

Fujirebio

KAINOS Laboratories

DiaSorin

Danaher Corporation

Siemens

Tellgen

DIACHA Diagnostics

Sichuan Maccura Biotechnology

Dirui

Chemclin IVD

TABLE OF CONTENT

1 Carbohydrate Antigen 19-9 Market Overview
1.1 Product Overview and Scope of Carbohydrate Antigen 19-9

1.2 Carbohydrate Antigen 19-9 Segment by Type

1.2.1 Global Carbohydrate Antigen 19-9 Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 ELISA

1.2.3 CLIA

1.3 Carbohydrate Antigen 19-9 Segment by Application

1.3.1 Global Carbohydrate Antigen 19-9 Sales Comparison by Application: (2022-2028)

1.3.2 Pancreatic Cancer

1.3.3 Colon Cancer

1.3.4 Stomach Cancer

1.3.5 Others

1.4 Global Carbohydrate Antigen 19-9 Market Size Estimates and Forecasts

1.4.1 Global Carbohydrate Antigen 19-9 Revenue 2017-2028

1.4.2 Global Carbohydrate Antigen 19-9 Sales 2017-2028

1.4.3 Carbohydrate Antigen 19-9 Market Size by Region: 2017 Versus 2021 Versus 2028

2 Carbohydrate Antigen 19-9 Market Competition by Manufacturers

2.1 Global Carbohydrate Antigen 19-9 Sales Market Share by Manufacturers (2017-2022)

2.2 Global Carbohydrate Antigen 19-9 Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Carbohydrate Antigen 19-9 Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Carbohydrate Antigen 19-9 Manufacturing Sites, Area Served, Product Type

2.5 Carbohydrate Antigen 19-9 Market Competitive Situation and Trends

2.5.1 Carbohydrate Antigen 19-9 Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Carbohydrate Antigen 19-9 Players Market Share by Revenue

2.5.3 Global Carbohydrate Antigen 19-9 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Carbohydrate Antigen 19-9 Retrospective Market Scenario by Region

3.1 Global Carbohydrate Antigen 19-9 Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Carbohydrate Antigen 19-9 Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Carbohydrate Antigen 19-9 Market Facts & Figures by Country

3.3.1 North America Carbohydrate Antigen 19-9 Sales by Country

3.3.2 North America Carbohydrate Antigen 19-9 Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe Carbohydrate Antigen 19-9 Market Facts & Figures by Country

3.4.1 Europe Carbohydrate Antigen 19-9 Sales by Country

3.4.2 Europe Carbohydrate Antigen 19-9 Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Carbohydrate Antigen 19-9 Market Facts & Figures by Region

3.5.1 Asia Pacific Carbohydrate Antigen 19-9 Sales by Region

3.5.2 Asia Pacific Carbohydrate Antigen 19-9 Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Carbohydrate Antigen 19-9 Market Facts & Figures by Country

3.6.1 Latin America Carbohydrate Antigen 19-9 Sales by Country

3.6.2 Latin America Carbohydrate Antigen 19-9 Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Carbohydrate Antigen 19-9 Market Facts & Figures by Country

3.7.1 Middle East and Africa Carbohydrate Antigen 19-9 Sales by Country

3.7.2 Middle East and Africa Carbohydrate Antigen 19-9 Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Carbohydrate Antigen 19-9 Historic Market Analysis by Type

4.1 Global Carbohydrate Antigen 19-9 Sales Market Share by Type (2017-2022)

4.2 Global Carbohydrate Antigen 19-9 Revenue Market Share by Type (2017-2022)

4.3 Global Carbohydrate Antigen 19-9 Price by Type (2017-2022)

5 Global Carbohydrate Antigen 19-9 Historic Market Analysis by Application

5.1 Global Carbohydrate Antigen 19-9 Sales Market Share by Application (2017-2022)

5.2 Global Carbohydrate Antigen 19-9 Revenue Market Share by Application (2017-2022)

5.3 Global Carbohydrate Antigen 19-9 Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Abbott

6.1.1 Abbott Corporation Information

6.1.2 Abbott Description and Business Overview

6.1.3 Abbott Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Abbott Carbohydrate Antigen 19-9 Product Portfolio

6.1.5 Abbott Recent Developments/Updates

6.2 Roche

6.2.1 Roche Corporation Information

6.2.2 Roche Description and Business Overview

6.2.3 Roche Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Roche Carbohydrate Antigen 19-9 Product Portfolio

6.2.5 Roche Recent Developments/Updates

6.3 Ortho Clinical Diagnostics

6.3.1 Ortho Clinical Diagnostics Corporation Information

6.3.2 Ortho Clinical Diagnostics Description and Business Overview

6.3.3 Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Ortho Clinical Diagnostics Carbohydrate Antigen 19-9 Product Portfolio

6.3.5 Ortho Clinical Diagnostics Recent Developments/Updates

6.4 BioMérieux

6.4.1 BioMérieux Corporation Information

6.4.2 BioMérieux Description and Business Overview

6.4.3 BioMérieux Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2017-2022)

6.4.4 BioMérieux Carbohydrate Antigen 19-9 Product Portfolio

6.4.5 BioMérieux Recent Developments/Updates

6.5 Fujirebio

6.5.1 Fujirebio Corporation Information

6.5.2 Fujirebio Description and Business Overview

6.5.3 Fujirebio Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Fujirebio Carbohydrate Antigen 19-9 Product Portfolio

6.5.5 Fujirebio Recent Developments/Updates

6.6 KAINOS Laboratories

6.6.1 KAINOS Laboratories Corporation Information

6.6.2 KAINOS Laboratories Description and Business Overview

6.6.3 KAINOS Laboratories Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2017-2022)

6.6.4 KAINOS Laboratories Carbohydrate Antigen 19-9 Product Portfolio

6.6.5 KAINOS Laboratories Recent Developments/Updates

6.7 DiaSorin

6.6.1 DiaSorin Corporation Information

6.6.2 DiaSorin Description and Business Overview

6.6.3 DiaSorin Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2017-2022)

6.4.4 DiaSorin Carbohydrate Antigen 19-9 Product Portfolio

6.7.5 DiaSorin Recent Developments/Updates

6.8 Danaher Corporation

6.8.1 Danaher Corporation Corporation Information

6.8.2 Danaher Corporation Description and Business Overview

6.8.3 Danaher Corporation Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Danaher Corporation Carbohydrate Antigen 19-9 Product Portfolio

6.8.5 Danaher Corporation Recent Developments/Updates

6.9 Siemens

6.9.1 Siemens Corporation Information

6.9.2 Siemens Description and Business Overview

6.9.3 Siemens Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Siemens Carbohydrate Antigen 19-9 Product Portfolio

6.9.5 Siemens Recent Developments/Updates

6.10 Tellgen

6.10.1 Tellgen Corporation Information

6.10.2 Tellgen Description and Business Overview

6.10.3 Tellgen Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Tellgen Carbohydrate Antigen 19-9 Product Portfolio

6.10.5 Tellgen Recent Developments/Updates

6.11 DIACHA Diagnostics

6.11.1 DIACHA Diagnostics Corporation Information

6.11.2 DIACHA Diagnostics Carbohydrate Antigen 19-9 Description and Business Overview

6.11.3 DIACHA Diagnostics Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2017-2022)

6.11.4 DIACHA Diagnostics Carbohydrate Antigen 19-9 Product Portfolio

6.11.5 DIACHA Diagnostics Recent Developments/Updates

6.12 Sichuan Maccura Biotechnology

6.12.1 Sichuan Maccura Biotechnology Corporation Information

6.12.2 Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Description and Business Overview

6.12.3 Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Sichuan Maccura Biotechnology Carbohydrate Antigen 19-9 Product Portfolio

6.12.5 Sichuan Maccura Biotechnology Recent Developments/Updates

6.13 Dirui

6.13.1 Dirui Corporation Information

6.13.2 Dirui Carbohydrate Antigen 19-9 Description and Business Overview

6.13.3 Dirui Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Dirui Carbohydrate Antigen 19-9 Product Portfolio

6.13.5 Dirui Recent Developments/Updates

6.14 Chemclin IVD

6.14.1 Chemclin IVD Corporation Information

6.14.2 Chemclin IVD Carbohydrate Antigen 19-9 Description and Business Overview

6.14.3 Chemclin IVD Carbohydrate Antigen 19-9 Sales, Revenue and Gross Margin (2017-2022)

6.14.4 Chemclin IVD Carbohydrate Antigen 19-9 Product Portfolio

6.14.5 Chemclin IVD Recent Developments/Updates

7 Carbohydrate Antigen 19-9 Manufacturing Cost Analysis

7.1 Carbohydrate Antigen 19-9 Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Carbohydrate Antigen 19-9

7.4 Carbohydrate Antigen 19-9 Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Carbohydrate Antigen 19-9 Distributors List

8.3 Carbohydrate Antigen 19-9 Customers

9 Carbohydrate Antigen 19-9 Market Dynamics

9.1 Carbohydrate Antigen 19-9 Industry Trends

9.2 Carbohydrate Antigen 19-9 Market Drivers

9.3 Carbohydrate Antigen 19-9 Market Challenges

9.4 Carbohydrate Antigen 19-9 Market Restraints

10 Global Market Forecast

10.1 Carbohydrate Antigen 19-9 Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Carbohydrate Antigen 19-9 by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Carbohydrate Antigen 19-9 by Type (2023-2028)

10.2 Carbohydrate Antigen 19-9 Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Carbohydrate Antigen 19-9 by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Carbohydrate Antigen 19-9 by Application (2023-2028)

10.3 Carbohydrate Antigen 19-9 Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Carbohydrate Antigen 19-9 by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Carbohydrate Antigen 19-9 by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample